These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 18270228)

  • 1. Use of bisphosphonates and dual-energy X-ray absorptiometry scans in the prevention and treatment of glucocorticoid-induced osteoporosis in rheumatology.
    Wall E; Walker-Bone K
    QJM; 2008 Apr; 101(4):317-23. PubMed ID: 18270228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening and treatment of glucocorticoid-induced osteoporosis in rheumatoid arthritis patients in an urban multispecialty practice.
    Ledwich LJ; Clarke K
    J Clin Rheumatol; 2009 Mar; 15(2):61-4. PubMed ID: 19265346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone safety of low-dose glucocorticoids in rheumatic diseases.
    Saag KG
    Ann N Y Acad Sci; 2014 May; 1318():55-64. PubMed ID: 24815076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of evaluation and treatment of glucocorticoid-induced osteoporosis in men.
    Cruse LM; Valeriano J; Vasey FB; Carter JD
    J Clin Rheumatol; 2006 Oct; 12(5):221-5. PubMed ID: 17023807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-sectional study of bisphosphonate use in dermatology patients receiving long-term oral corticosteroid therapy.
    Liu RH; Albrecht J; Werth VP
    Arch Dermatol; 2006 Jan; 142(1):37-41. PubMed ID: 16415384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A survey of steroid-related osteoporosis diagnosis, prevention and treatment practices of pediatric rheumatologists in North America.
    Soybilgic A; Tesher M; Wagner-Weiner L; Onel KB
    Pediatr Rheumatol Online J; 2014; 12():24. PubMed ID: 25053923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Secondary osteoporosis UPDATE. Clinical significance of glucocorticoid-induced osteoporosis].
    Suzuki Y; Sato S
    Clin Calcium; 2010 May; 20(5):645-53. PubMed ID: 20445275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options.
    De Nijs RN
    Minerva Med; 2008 Feb; 99(1):23-43. PubMed ID: 18299694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Guidelines for the treatment of glucocorticoid-induced osteoporosis and their future problems].
    Soen S
    Clin Calcium; 2006 Nov; 16(11):1788-96. PubMed ID: 17079844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to prevent glucocorticoid-induced osteoporosis.
    Dore RK
    Cleve Clin J Med; 2010 Aug; 77(8):529-36. PubMed ID: 20682515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current topics over updating guidelines on the management and treatment of glucocorticoid-induced osteoporosis].
    Suzuki Y
    Clin Calcium; 2014 Mar; 24(3):417-24. PubMed ID: 24576939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: rates and predictors of care in an academic rheumatology practice.
    Solomon DH; Katz JN; Jacobs JP; La Tourette AM; Coblyn J
    Arthritis Rheum; 2002 Dec; 46(12):3136-42. PubMed ID: 12483716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnosis and treatment of osteoporosis and rheumatoid arthritis in accordance with German guidelines. Results of a survey of patients, primary care physicians and rheumatologists].
    Heberlein I; Demary W; Bloching H; Braun J; Buttgereit F; Dreher R; Kuhn C; Lange U; Zink A; Zeidler H; Häntzschel H; Raspe H
    Z Rheumatol; 2011 Sep; 70(7):592-601. PubMed ID: 21755301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis.
    Arthritis Rheum; 2001 Jul; 44(7):1496-503. PubMed ID: 11465699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoid-induced osteoporosis: pathogenesis, diagnosis, and management.
    McIlwain HH
    Prev Med; 2003 Feb; 36(2):243-9. PubMed ID: 12591000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of bisphosphonate might be important to improve bone mineral density in patients with rheumatoid arthritis even under tight control: the TOMORROW study.
    Tada M; Inui K; Sugioka Y; Mamoto K; Okano T; Anno S; Koike T
    Rheumatol Int; 2017 Jun; 37(6):999-1005. PubMed ID: 28405825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoid-induced osteoporosis and its treatment.
    Pennisi P; Trombetti A; Rizzoli R
    Clin Orthop Relat Res; 2006 Feb; 443():39-47. PubMed ID: 16462424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Glucocorticoid-induced osteoporosis : treatment update].
    Soen S
    Clin Calcium; 2012 Feb; 22(2):229-35. PubMed ID: 22298077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevention and treatment of glucocorticoid-induced osteoporosis in clinical practice.
    Walker-Bone K; Wood A; Hull R; Ledingham JM; McCrae FC; Shaban R; Thomas A; Mackay K
    Clin Med (Lond); 2004; 4(5):431-6. PubMed ID: 15536872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary osteoporosis: underlying disease and the risk for glucocorticoid-induced osteoporosis.
    Boling EP
    Clin Ther; 2004 Jan; 26(1):1-14. PubMed ID: 14996513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.